Search
for
Sort by
Research 511–540 of 1000+
- Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
- Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Infertility in Polycystic Ovary Syndrome: Focus on Low-Dose Gonadotropin Treatment
- Repurposing of approved cardiovascular drugs
- Exosomes and Their Bioengineering Strategies in the Cutaneous Wound Healing and Related Complications: Current Knowledge and Future Perspectives
- Niosomes as a propitious carrier for topical drug delivery
- Acne as a chronic systemic disease
- Physiological and biological skin changes in pregnancy
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Telogen effluvium
- Alopecia areata: An update
- The Hair Follicle: A Paradoxical Androgen Target Organ
- Menstrual Irregularity in Women with Acromegaly
- Androgenic Effects on Ventricular Repolarization
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
- Photodynamic and photobiological effects of light-emitting diode (LED) therapy in dermatological disease: an update
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- Topical Application of the Synthetic Triterpenoid RTA 408 Protects Mice from Radiation-Induced Dermatitis
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
- COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine
- Graft-versus-host disease
- Association of Surgical Risk With Exogenous Hormone Use in Transgender Patients
- Skin Manifestations in Primary Immunodeficient Children
- Established risk factors for coronary heart disease are unrelated to androgen-induced baldness in female-to-male transsexuals
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications